SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Punglia RS, Hughes ME, Edge SB, et al. Factors associated with guideline-concordant use of radiotherapy after mastectomy in the national comprehensive cancer network. Int J Radiat Oncol Biol Phys. 2008; 72: 1434-1440.
  • 2
    Smith TJ, Hillner BE. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. J Clin Oncol. 2001; 19: 2886-2897.
  • 3
    Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst. 2001; 93: 979-989.
  • 4
    Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999; 44: 989-990.
  • 5
    Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001; 19: 1539-1569.
  • 6
    Carlson RW, Edge SB, Theriault RL. NCCN: breast cancer. Cancer Control. 2001; 8( 6 suppl 2): 54-61.
  • 7
    Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997; 337: 949-955.
  • 8
    Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997; 337: 956-962.
  • 9
    Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999; 353: 1641-1648.
  • 10
    Punglia RS, Weeks JC, Neville BA, Earle CC. Radiation therapy after mastectomy between 1991 and 1999 in elderly women: response to clinical trial information. J Clin Oncol. 2006; 24: 3474-3482.
  • 11
    Smith BD, Haffty BG, Smith GL, Hurria A, Buchholz TA, Gross CP. Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys. 2008; 71: 98-106.
  • 12
    SCOPUS Database. SciVerse Scopus. http://www.scopus. com/home.url. Amsterdam, the Netherlands: Elsevier BV; 2011. Accessed January 31, 2011.
  • 13
    Virnig BA, Warren JL, Cooper GS, Klabunde CN, Schussler N, Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care. 2002; 40( 8 suppl): IV-49-IV-54.
  • 14
    Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked Medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol. 1999; 52: 463-470.
  • 15
    Centers for Disease Control and Prevention/National Center for Health Statistics.International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). 3rd ed. Volumes 1-3. Los Angeles, Calif: Practice Management Information Corporation; 1991.
  • 16
    Buck CJ. International Classification of Diseases, 9th Revision Clinical Modification. (ICD-9-CM). Volumes 1-3 and Healthcare Common Procedure Coding System (HCPCS) Level II. Philadelphia, PA: WB Saunders Company; 2002.
  • 17
    Kirschner CG, Edwards NK, May DM, et al. eds. Physicians' Current Procedural Terminology. 4th ed. Chicago, IL: American Medical Association; 1991.
  • 18
    Anderson CA, Beebe M, Dalton JA, et al, eds. Current Procedural Terminology (CPT). Chicago, IL: American Medical Association; 2002.
  • 19
    Du X, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Med Care. 2000; 38: 719-727.
  • 20
    Warren JL, Harlan LC, Fahey A, et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care. 2002; 40( 8 suppl): IV-55-IV-61.
  • 21
    Du XL, Chan W, Giordano S, et al. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer. 2005; 104: 913-924.
  • 22
    Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Res Treat. 2005; 93: 41-47.
  • 23
    Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ. Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol. 2006; 24: 85-94.
  • 24
    Bach PB, Guadagnoli E, Schrag D, Schussler N, Warren JL. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care. 2002; 40( 8 suppl): IV-19-IV-25.
  • 25
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
  • 26
    Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992; 45: 613-619.
  • 27
    Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993; 46: 1075-1079; discussion 1081-1090.
  • 28
    Klabunde CN, Potosky AL, Legler JM, Warren JL. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000; 53: 1258-1267.
  • 29
    Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002; 40( 8 suppl): IV-26-IV-35.
  • 30
    Makuc DM, Haglund B, Ingram DD, Kleinman JC, Feldman JJ. Health service areas for the United States. Vital Health Stat. 1991; 2: 1-102.
  • 31
    Fritz A, Percy C, Jack A, et al, eds. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 32
    Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Handbook. 6th ed. New York: Springer; 2002.
  • 33
    Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335-351.
  • 34
    National Cancer Institute, Statistical Research and Applications Branch. Joinpoint Regression Program, Version 3.0. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2005.
  • 35
    Floyd SR, Buchholz TA, Haffty BG, et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. Int J Radiat Oncol Biol Phys. 2006; 66: 358-364.
  • 36
    Taghian AG, Jeong JH, Mamounas EP, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from 5 National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2006; 24: 3927-3932.
  • 37
    Punglia RS, Weeks JC, Neville BA, Earle CC. Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women. Int J Radiat Oncol Biol Phys. 2006; 66: 56-63.
  • 38
    Jagsi R, Abrahamse P, Morrow M, et al. Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer. J Clin Oncol. 2010; 28: 2396-2403.
  • 39
    Steenland K, Henley J, Thun M. All-cause and cause-specific death rates by educational status for 2 million people in 2 American Cancer Society cohorts, 1959-1996. Am J Epidemiol. 2002; 156: 11-21.
  • 40
    Smith GL, Shih YC, Xu Y, et al. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study. Cancer. 2010; 116: 734-741.
  • 41
    Jagsi R, Abrahamse P, Morrow M, Griggs JJ, Schwartz K, Katz SJ. Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process. Cancer. 2009; 115: 1185-1193.
  • 42
    Olivotto A, Coldman AJ, Hislop TG, et al. Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol. 1997; 15: 216-222.
  • 43
    Ray-Coquard I, Philip T, Lehmann M, Fervers B, Farsi F, Chauvin F. Impact of a clinical guidelines program for breast and colon cancer in a French cancer center. JAMA. 1997; 278: 1591-1595.
  • 44
    Ford LG, Hunter CP, Diehr P, Frelick RW, Yates J. Effects of patient management guidelines on physician practice patterns: the Community Hospital Oncology Program experience. J Clin Oncol. 1987; 5: 504-511.
  • 45
    Grilli R, Apolone G, Marsoni S, Nicolucci A, Zola P, Liberati A. The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care. 1991; 29: 50-63.
  • 46
    Winchester DP. The National Accreditation Program for Breast Centers: a multidisciplinary approach to improve the quality of care for patients with diseases of the breast. Breast J. 2008; 14: 409-411.